Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy

Atsuya Takeda, Etsuo Kunieda, Naoko Sanuki, Toshio Ohashi, Yohei Oku, Yasunobu Sudo, Hideo Iwashita, Yoshikazu Ooka, Yosuke Aoki, Naoyuki Shigematsu, Atsushi Kubo

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Purpose: We have used dynamic conformal multiple arc therapy (DCMAT) for stereotactic body radiotherapy (SBRT) since 2001. We investigated the consistency of DCMAT for SBRT using dose-volume histogram analysis. Methods and Materials: A total of 50 patients with peripheral lung tumors underwent SBRT. The median tumor diameter was 2.4 cm (range, 0.9-5.9). Treatment planning was performed using a superposition algorithm. The prescribed 50 Gy dose was divided into five fractions. The prescribed dose was defined as 80% of the maximal dose in the planning target volume (PTV), and the leaf margins were modified to ensure the PTV was included in the 80% isodose surface. The dose-volume histogram analysis was used to assess the PTV and normal lung volume. Results: The median dose covering 95% of the PTV was 50.27 Gy (range, 46.14-52.67), essentially consistent with the prescribed dose. The median homogeneity and conformity index was 1.41 (range, 1.31-1.53) and 1.73 (range, 1.41-2.21), respectively. The median volume of lung receiving ≥20 Gy (V20) was 4.2% (range, 1.4-10.2%). A linear correlation was found between the tumor diameter and V20, and an even stronger correlation was found between the PTV/(normal lung volume) and V20. The estimated V20 was 7.1% (range, 3.9-10.4%) for a 5-cm-diameter tumor, assumed to be the maximal size limitation for SBRT. Conclusion: SBRT with DCMAT achieved high conformity and delivered adequate doses within the PTV. The median dose covering 95% of the PTV was consistent with the prescribed dose. V20 can be estimated using the tumor diameter and normal lung volume. DCMAT was thus both a feasible and a reproducible method of SBRT delivery.

Original languageEnglish
Pages (from-to)363-369
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume74
Issue number2
DOIs
Publication statusPublished - 2009 Jun 1

Fingerprint

Radiosurgery
radiation therapy
therapy
arcs
dosage
planning
Lung
lungs
Neoplasms
tumors
Therapeutics
histograms
coverings
leaves
homogeneity
margins
delivery

Keywords

  • Dose distribution analysis
  • Dynamic conformal multiple arc therapy
  • Lung cancer
  • Stereotactic body radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy. / Takeda, Atsuya; Kunieda, Etsuo; Sanuki, Naoko; Ohashi, Toshio; Oku, Yohei; Sudo, Yasunobu; Iwashita, Hideo; Ooka, Yoshikazu; Aoki, Yosuke; Shigematsu, Naoyuki; Kubo, Atsushi.

In: International Journal of Radiation Oncology Biology Physics, Vol. 74, No. 2, 01.06.2009, p. 363-369.

Research output: Contribution to journalArticle

Takeda, Atsuya ; Kunieda, Etsuo ; Sanuki, Naoko ; Ohashi, Toshio ; Oku, Yohei ; Sudo, Yasunobu ; Iwashita, Hideo ; Ooka, Yoshikazu ; Aoki, Yosuke ; Shigematsu, Naoyuki ; Kubo, Atsushi. / Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy. In: International Journal of Radiation Oncology Biology Physics. 2009 ; Vol. 74, No. 2. pp. 363-369.
@article{856f9e584d3d4b7c8801c0d788fc8884,
title = "Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy",
abstract = "Purpose: We have used dynamic conformal multiple arc therapy (DCMAT) for stereotactic body radiotherapy (SBRT) since 2001. We investigated the consistency of DCMAT for SBRT using dose-volume histogram analysis. Methods and Materials: A total of 50 patients with peripheral lung tumors underwent SBRT. The median tumor diameter was 2.4 cm (range, 0.9-5.9). Treatment planning was performed using a superposition algorithm. The prescribed 50 Gy dose was divided into five fractions. The prescribed dose was defined as 80{\%} of the maximal dose in the planning target volume (PTV), and the leaf margins were modified to ensure the PTV was included in the 80{\%} isodose surface. The dose-volume histogram analysis was used to assess the PTV and normal lung volume. Results: The median dose covering 95{\%} of the PTV was 50.27 Gy (range, 46.14-52.67), essentially consistent with the prescribed dose. The median homogeneity and conformity index was 1.41 (range, 1.31-1.53) and 1.73 (range, 1.41-2.21), respectively. The median volume of lung receiving ≥20 Gy (V20) was 4.2{\%} (range, 1.4-10.2{\%}). A linear correlation was found between the tumor diameter and V20, and an even stronger correlation was found between the PTV/(normal lung volume) and V20. The estimated V20 was 7.1{\%} (range, 3.9-10.4{\%}) for a 5-cm-diameter tumor, assumed to be the maximal size limitation for SBRT. Conclusion: SBRT with DCMAT achieved high conformity and delivered adequate doses within the PTV. The median dose covering 95{\%} of the PTV was consistent with the prescribed dose. V20 can be estimated using the tumor diameter and normal lung volume. DCMAT was thus both a feasible and a reproducible method of SBRT delivery.",
keywords = "Dose distribution analysis, Dynamic conformal multiple arc therapy, Lung cancer, Stereotactic body radiotherapy",
author = "Atsuya Takeda and Etsuo Kunieda and Naoko Sanuki and Toshio Ohashi and Yohei Oku and Yasunobu Sudo and Hideo Iwashita and Yoshikazu Ooka and Yosuke Aoki and Naoyuki Shigematsu and Atsushi Kubo",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.ijrobp.2008.08.012",
language = "English",
volume = "74",
pages = "363--369",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy

AU - Takeda, Atsuya

AU - Kunieda, Etsuo

AU - Sanuki, Naoko

AU - Ohashi, Toshio

AU - Oku, Yohei

AU - Sudo, Yasunobu

AU - Iwashita, Hideo

AU - Ooka, Yoshikazu

AU - Aoki, Yosuke

AU - Shigematsu, Naoyuki

AU - Kubo, Atsushi

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Purpose: We have used dynamic conformal multiple arc therapy (DCMAT) for stereotactic body radiotherapy (SBRT) since 2001. We investigated the consistency of DCMAT for SBRT using dose-volume histogram analysis. Methods and Materials: A total of 50 patients with peripheral lung tumors underwent SBRT. The median tumor diameter was 2.4 cm (range, 0.9-5.9). Treatment planning was performed using a superposition algorithm. The prescribed 50 Gy dose was divided into five fractions. The prescribed dose was defined as 80% of the maximal dose in the planning target volume (PTV), and the leaf margins were modified to ensure the PTV was included in the 80% isodose surface. The dose-volume histogram analysis was used to assess the PTV and normal lung volume. Results: The median dose covering 95% of the PTV was 50.27 Gy (range, 46.14-52.67), essentially consistent with the prescribed dose. The median homogeneity and conformity index was 1.41 (range, 1.31-1.53) and 1.73 (range, 1.41-2.21), respectively. The median volume of lung receiving ≥20 Gy (V20) was 4.2% (range, 1.4-10.2%). A linear correlation was found between the tumor diameter and V20, and an even stronger correlation was found between the PTV/(normal lung volume) and V20. The estimated V20 was 7.1% (range, 3.9-10.4%) for a 5-cm-diameter tumor, assumed to be the maximal size limitation for SBRT. Conclusion: SBRT with DCMAT achieved high conformity and delivered adequate doses within the PTV. The median dose covering 95% of the PTV was consistent with the prescribed dose. V20 can be estimated using the tumor diameter and normal lung volume. DCMAT was thus both a feasible and a reproducible method of SBRT delivery.

AB - Purpose: We have used dynamic conformal multiple arc therapy (DCMAT) for stereotactic body radiotherapy (SBRT) since 2001. We investigated the consistency of DCMAT for SBRT using dose-volume histogram analysis. Methods and Materials: A total of 50 patients with peripheral lung tumors underwent SBRT. The median tumor diameter was 2.4 cm (range, 0.9-5.9). Treatment planning was performed using a superposition algorithm. The prescribed 50 Gy dose was divided into five fractions. The prescribed dose was defined as 80% of the maximal dose in the planning target volume (PTV), and the leaf margins were modified to ensure the PTV was included in the 80% isodose surface. The dose-volume histogram analysis was used to assess the PTV and normal lung volume. Results: The median dose covering 95% of the PTV was 50.27 Gy (range, 46.14-52.67), essentially consistent with the prescribed dose. The median homogeneity and conformity index was 1.41 (range, 1.31-1.53) and 1.73 (range, 1.41-2.21), respectively. The median volume of lung receiving ≥20 Gy (V20) was 4.2% (range, 1.4-10.2%). A linear correlation was found between the tumor diameter and V20, and an even stronger correlation was found between the PTV/(normal lung volume) and V20. The estimated V20 was 7.1% (range, 3.9-10.4%) for a 5-cm-diameter tumor, assumed to be the maximal size limitation for SBRT. Conclusion: SBRT with DCMAT achieved high conformity and delivered adequate doses within the PTV. The median dose covering 95% of the PTV was consistent with the prescribed dose. V20 can be estimated using the tumor diameter and normal lung volume. DCMAT was thus both a feasible and a reproducible method of SBRT delivery.

KW - Dose distribution analysis

KW - Dynamic conformal multiple arc therapy

KW - Lung cancer

KW - Stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=65449173478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449173478&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2008.08.012

DO - 10.1016/j.ijrobp.2008.08.012

M3 - Article

C2 - 19427552

AN - SCOPUS:65449173478

VL - 74

SP - 363

EP - 369

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -